Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy
- PMID: 22036767
- PMCID: PMC3243676
- DOI: 10.1093/jnci/djr439
Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy
Comment on
-
Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.J Natl Cancer Inst. 2011 Jun 22;103(12):910-3. doi: 10.1093/jnci/djr195. Epub 2011 Jun 13. J Natl Cancer Inst. 2011. PMID: 21670422 Free PMC article. No abstract available.
Similar articles
-
Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.J Natl Cancer Inst. 2011 Jun 22;103(12):910-3. doi: 10.1093/jnci/djr195. Epub 2011 Jun 13. J Natl Cancer Inst. 2011. PMID: 21670422 Free PMC article. No abstract available.
-
Under-dosing study raises questions about ways to improve regimen adherence.J Natl Cancer Inst. 2004 Aug 18;96(16):1201-2. doi: 10.1093/jnci/96.16.1201. J Natl Cancer Inst. 2004. PMID: 15316053 No abstract available.
-
The importance of prophylactic management of chemotherapy-induced neutropenia.Anticancer Drugs. 2003 Oct;14(9):725-30. doi: 10.1097/00001813-200310000-00006. Anticancer Drugs. 2003. PMID: 14551505 Review.
-
Myeloid growth factor therapy for prophylaxis of febrile neutropenia in non-myeloid malignancies: appropriate doses and schedules.J Natl Compr Canc Netw. 2007 Feb;5(2):229-34. doi: 10.6004/jnccn.2007.0022. J Natl Compr Canc Netw. 2007. PMID: 17335691
-
Colony-stimulating factors for the management of neutropenia in cancer patients.Drugs. 2002;62 Suppl 1:1-15. doi: 10.2165/00003495-200262001-00001. Drugs. 2002. PMID: 12479591 Review.
References
-
- Crawford J, Althaus B, Armitage J, et al. Myeloid growth factors. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2007;5(2):188–202. - PubMed
-
- Smith TJ, Khatcheressian J, Lyman GH, et al. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol. 2006;24(19):3187–3205. - PubMed
-
- Aapro MS, Bohlius J, Cameron DA, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 2011;47(1):8–32. - PubMed